𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pertuzumab plus trastuzumab and docetaxel in HER2-positive metastatic breast cancer

✍ Scribed by Jame Abraham

Book ID
119219235
Publisher
Frontline Medical Communications, Inc.
Year
2012
Tongue
English
Weight
100 KB
Volume
9
Category
Article
ISSN
1548-5315

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pertuzumab plus Trastuzumab plus Docetax
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
✍ Baselga, JosΓ©; CortΓ©s, Javier; Kim, Sung-Bae; Im, Seock-Ah; Hegg, Roberto; Im, Y πŸ“‚ Article πŸ“… 2012 πŸ› Massachusetts Medical Society 🌐 English βš– 661 KB

## Background: The anti-human epidermal growth factor receptor 2 (her2) humanized monoclonal antibody trastuzumab improves the outcome in patients with her2-positive metastatic breast cancer. however, most cases of advanced disease eventually progress. pertuzumab, an anti-her2 humanized monoclonal

Pertuzumab in HER2-positive breast cance
Pertuzumab in HER2-positive breast cancer
✍ Sendur, Mehmet A.N.; Aksoy, Sercan; Altundag, Kadri πŸ“‚ Article πŸ“… 2012 πŸ› Informa plc 🌐 English βš– 675 KB